全球脊髓刺激设备市场规模、份额、趋势和成长分析报告（2026-2034年）

预计脊髓刺激设备市场将从 2025 年的 30.3 亿美元成长到 2034 年的 65.1 亿美元，2026 年至 2034 年的复合年增长率为 8.86%。

由于慢性疼痛和神经系统疾病的盛行率不断上升，全球脊髓刺激设备市场正经历显着成长。这些设备广泛用于对传统治疗方法无效的患者的疼痛管理。人们对微创疼痛管理方案的认识不断提高，推动了患者的接受度。植入式装置的科技进步正在改善病患的舒适度、安全性和整体治疗效果。

推动市场发展的关键因素包括全球人口老化、腰痛发病率上升以及人们对非鸦片类镇痛方案日益增长的偏好。医疗服务提供者越来越多地推荐脊髓刺激疗法作为长期药物治疗的替代方案。更完善的报销政策和支持性的法规结构也促进了市场扩张。製造商正致力于开发可充电和无线设备，以提高便利性和患者满意度。

随着神经调控技术的不断创新，脊髓刺激设备市场前景依然强劲。设备小型化、电池续航时间和编程功能的提升可望改善临床疗效。发展中地区医疗保健覆盖范围的扩大也可能进一步刺激市场需求。随着全球对慢性疼痛管理日益增长的关注，脊髓刺激设备将在改善患者生活品质方面发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球脊髓刺激设备市场：依适应症划分

• 市场分析、洞察与预测
• Failed Back Surgery Syndrome
• 复杂性局部疼痛症候群
• 退化性椎间盘病变
• 其他的

第五章 全球脊髓刺激设备市场：依产品划分

• 市场分析、洞察与预测
• 可充电装置
• 不可充电设备

第六章：全球脊髓刺激设备市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他的

第七章 全球脊髓刺激设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Saluda Medical Pty Ltd
  • Nevro Corporation
  • Abbott Laboratories
  • Nalu Medical Inc
  • GIMER MEDICAL
  • Beijing PINS Medical Co. Ltd
  • Teliatry Inc
  • Medtronic Plc
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG

The Spinal Cord Stimulation Devices Market size is expected to reach USD 6.51 Billion in 2034 from USD 3.03 Billion (2025) growing at a CAGR of 8.86% during 2026-2034.

The Global Spinal Cord Stimulation Devices Market is witnessing significant growth due to the increasing prevalence of chronic pain conditions and neurological disorders. These devices are widely used to manage pain that does not respond to conventional treatments. Growing awareness about minimally invasive pain management options is encouraging patient adoption. Technological advancements in implantable devices are improving patient comfort, safety, and overall treatment effectiveness.

Key market drivers include the aging global population, rising incidence of back pain, and increasing preference for non-opioid pain management solutions. Healthcare providers are increasingly recommending spinal cord stimulation as an alternative to long-term medication use. Improved reimbursement policies and supportive regulatory frameworks are also facilitating market expansion. Manufacturers are focusing on developing rechargeable and wireless devices to enhance convenience and patient satisfaction.

Future prospects for the spinal cord stimulation devices market remain strong as innovation continues in neuromodulation technologies. Advances in device miniaturization, battery life, and programming capabilities are expected to enhance clinical outcomes. Expanding healthcare access in developing regions may further boost demand. As the focus on chronic pain management intensifies globally, spinal cord stimulation devices are likely to play a crucial role in improving patients' quality of life.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Indication

• Failed Back Surgery Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disc Disease
• Others

By Product

• Rechargeable Devices
• Non-Rechargeable Devices

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Saluda Medical Pty Ltd, Nevro Corporation, Abbott Laboratories, Nalu Medical Inc, GIMER MEDICAL, Beijing PINS Medical Co Ltd, Teliatry Inc, Medtronic plc, Boston Scientific Corporation, BIOTRONIK SE amp Co KG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Indication
• 4.2. Failed Back Surgery Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Complex Regional Pain Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Degenerative Disc Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Rechargeable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Non-Rechargeable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Indication
  • 7.2.2 By Product
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Indication
  • 7.3.2 By Product
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Indication
  • 7.4.2 By Product
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Indication
  • 7.5.2 By Product
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Indication
  • 7.6.2 By Product
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SPINAL CORD STIMULATION DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Saluda Medical Pty Ltd
  • 9.2.2 Nevro Corporation
  • 9.2.3 Abbott Laboratories
  • 9.2.4 Nalu Medical Inc
  • 9.2.5 GIMER MEDICAL
  • 9.2.6 Beijing PINS Medical Co. Ltd
  • 9.2.7 Teliatry Inc
  • 9.2.8 Medtronic Plc
  • 9.2.9 Boston Scientific Corporation
  • 9.2.10 BIOTRONIK SE & Co. KG